Please wait while the formulary information is being retrieved.
KAPVAY (CLONIDINE HCL)
- Attention-deficit hyperactivity disorder
- Kapvay Tablet,extended Release
- Clonidine Hcl Er Tablet,extended Release,12 Hr
- Clonidine Er Tablet,extended Release,12 Hr
0.1 mg tablet,extended release
- Dosage information is not available
0.1 mg tablet,extended release,12 hr
- Dosage information is not available
ER 0.1 mg tablet,extended release,12 hr
- Dosage information is not available
0.1 mg tablet,extended release,12 hr
- Dosage information is not available
- None
Contraindicated
- acebutolol
- atenolol
- atenolol-chlorthalidone
- Betagan
- Betapace
- Betapace Af
- betaxolol
- Betimol
- Betoptic S
- bisoprolol fumarate
- bisoprolol-hydrochlorothiazide
- Brevibloc
- Brevibloc In Nacl (iso-osm)
- brimonidine-timolol
- Bystolic
- carteolol
- carvedilol
- carvedilol phosphate
- Combigan
- Coreg
- Coreg Cr
- Corgard
- Corzide
- Cosopt
- Cosopt Pf
- dorzolamide-timolol
- dorzolamide-timolol (PF)
- Dutoprol
- esmolol
- esmolol in NaCl (iso-osm)
- Inderal La
- Inderal Xl
- Innopran Xl
- Istalol
- labetalol
- Levatol
- levobunolol
- Lopressor
- Lopressor Hct
- metipranolol
- metoprolol su-hydrochlorothiaz
- metoprolol succinate
- metoprolol ta-hydrochlorothiaz
- metoprolol tartrate
- nadolol
- nadolol-bendroflumethiazide
- nebivolol
- penbutolol
- pindolol
- propranolol
- propranolol-hydrochlorothiazid
- Sectral
- Sorine
- sotalol
- Sotalol Af
- Tenoretic 100
- Tenoretic 50
- Tenormin
- timolol
- timolol maleate
- timolol maleate (PF)
- Timoptic
- Timoptic Ocudose (pf)
- Timoptic-xe
- Toprol Xl
- Trandate
- Zebeta
- Ziac
Severe
Moderate
- amitriptyline
- amitriptyline-chlordiazepoxide
- amoxapine
- Amrix
- Anafranil
- clomipramine
- cyclobenzaprine
- cyclobenzaprine with msm
- desipramine
- doxepin
- imipramine HCl
- imipramine pamoate
- mirtazapine
- Norpramin
- nortriptyline
- Pamelor
- perphenazine-amitriptyline
- protriptyline
- Prudoxin
- Remeron
- Remeron Soltab
- Silenor
- Surmontil
- Tabradol
- Tofranil
- Tofranil-pm
- trimipramine
- Vivactil
- Zonalon
- None
Contraindicated
- Atrioventricular block
- Depression
- Invasive surgical procedure
- Raynaud's phenomenon
- Sinus bradycardia
Severe
Moderate
- Acute myocardial infarction
- Cerebrovascular disorder
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
- Chronic myocardial ischemia
- Dry eye
KAPVAY (CLONIDINE HCL)
- Attention-deficit hyperactivity disorder
- None
- Constipation
- Dizziness
- Drowsy
- Fatigue
- General weakness
- Xerostomia
More Frequent
Severe
Less Severe
- Depression
- Abnormal sexual function
- Anorexia
- Dry eye
- Earache
- Erectile dysfunction
- Irritability
- Nasal congestion
- Nausea
- Nervousness
- Ocular irritation
- Ocular itching
- Orthostatic hypotension
- Sore throat
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal ECG
- Angioedema
- Atrioventricular block
- Bradycardia
- Chronic heart failure
- Hepatitis
- Hypotension
- Nightmares
- Raynaud's phenomenon
Less Severe
- Abdominal pain with cramps
- Accommodation disorder
- Agitation
- Blurred vision
- Cramps in legs
- Delirium
- Delusional disorder
- Dry nose
- Fever
- Gynecomastia
- Hallucinations
- Headache disorder
- Insomnia
- Myalgias
- Nocturia
- Pallor
- Paresthesia
- Sleep disorder
- Symptoms of anxiety
- Urinary retention
- Weight gain
Contraindicated
None
Severe Precaution
Clonidine (Ext. Release)
No safety and efficacy age < 6 years.
- 1 Day – 6 Years
- No safety and efficacy age < 6 years.
Management or Monitoring Precaution
Clonidine (Ext. Release)
More sensitive to effects of CNS depression. Rare reports of hallucinations, prolonged QT interval.
- 6 Years – 18 Years
- More sensitive to effects of CNS depression. Rare reports of hallucinations, prolonged QT interval.
Clonidine Hydrochloride
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Clonidine
Potential adverse effects to infant.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Potential adverse effects to infant. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Attention-deficit hyperactivity disorder | |
| F90 | Attention-deficit hyperactivity disorders |
| F90.0 | Attention-deficit hyperactivity disorder, predominantly inattentive type |
| F90.1 | Attention-deficit hyperactivity disorder, predominantly hyperactive type |
| F90.2 | Attention-deficit hyperactivity disorder, combined type |
| F90.8 | Attention-deficit hyperactivity disorder, other type |
| F90.9 | Attention-deficit hyperactivity disorder, unspecified type |
| 0-9 | A-Z |
|---|---|
| F90 | Attention-deficit hyperactivity disorders |
| F90.0 | Attention-deficit hyperactivity disorder, predominantly inattentive type |
| F90.1 | Attention-deficit hyperactivity disorder, predominantly hyperactive type |
| F90.2 | Attention-deficit hyperactivity disorder, combined type |
| F90.8 | Attention-deficit hyperactivity disorder, other type |
| F90.9 | Attention-deficit hyperactivity disorder, unspecified type |
Formulary Reference Tool